ACADIA Pharmaceuticals SG&A Expense (Quarterly) Trends

ACADIA Pharmaceuticals Inc (ACAD)

16.60 -0.13 (-0.78%) USD | NASDAQ | Apr 24, 16:00

16.60 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2004. Upgrade now.

Date	Value
December 31, 2023	111.46M
September 30, 2023	97.89M
June 30, 2023	95.97M
March 31, 2023	101.24M
December 31, 2022	104.40M
September 30, 2022	78.11M
June 30, 2022	89.90M
March 31, 2022	96.68M
December 31, 2021	105.91M
September 30, 2021	81.67M
June 30, 2021	96.79M
March 31, 2021	111.66M
December 31, 2020	120.75M
September 30, 2020	81.59M
June 30, 2020	84.34M
March 31, 2020	101.97M
December 31, 2019	91.87M
September 30, 2019	72.70M
June 30, 2019	67.98M
March 31, 2019	93.09M
December 31, 2018	74.27M
September 30, 2018	61.09M
June 30, 2018	69.47M
March 31, 2018	60.93M
December 31, 2017	66.69M

Date	Value
September 30, 2017	61.59M
June 30, 2017	61.12M
March 31, 2017	65.66M
December 31, 2016	57.66M
September 30, 2016	50.53M
June 30, 2016	50.77M
March 31, 2016	27.49M
December 31, 2015	22.62M
September 30, 2015	20.31M
June 30, 2015	21.12M
March 31, 2015	24.26M
December 31, 2014	10.42M
September 30, 2014	8.057M
June 30, 2014	7.952M
March 31, 2014	6.32M
December 31, 2013	4.276M
September 30, 2013	3.797M
June 30, 2013	2.496M
March 31, 2013	2.151M
December 31, 2012	2.298M
September 30, 2012	1.485M
June 30, 2012	1.556M
March 31, 2012	1.66M
December 31, 2011	1.478M
September 30, 2011	1.519M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

67.98M

Minimum

Jun 2019

120.75M

Maximum

Dec 2020

94.36M

Average

96.68M

Median

Mar 2022

SG&A Expense (Quarterly) Benchmarks